Trademarkia Logo

Canada

C$
Trademark Search in Canada
Scinai Immunotherapeutics

View On IC.GC.CA

Scinai Immunotherapeutics
SEARCHED

on 25 Mar 2025

Last Applicant/ Owned by

Scinai Immunotherapeutics Ltd.

Jerusalem BioPark Building, 2nd Floor,Hadassah Ein Kerem CampusJerusalem

IL

Serial Number

2304555 filed on 22nd Aug 2023

Scinai Immunotherapeutics

Trademark usage description

antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metaboli Read More

Classification Information

Class [005]
Antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, neurogenerative diseases; immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, neurogenerative diseases.

Classification kind code

12

Mark Details

Serial Number

2304555

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 25th Mar 2025		Search Recorded
Submitted for opposition 20
on 25th Mar 2025		Examiner's First Report
Submitted for opposition 223
on 25th Mar 2025		Total Provisional Refusal
Submitted for opposition 256
on 11th Nov 2024		Notification of Possible Opposition Sent
Submitted for opposition 135
on 18th Jul 2024		Amendment to Application
Submitted for opposition 257
on 11th Jan 2024		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 10th Jan 2024		Created
Submitted for opposition 31
on 10th Jan 2024		Formalized
Submitted for opposition 228
on 22nd Aug 2023		International Registration
Submitted for opposition 30
on 22nd Aug 2023		Filed